Stock listing

OVID Stock Price, News, Filings & Events — Ovid Therapeutics Inc.

Selected listing: OVID · BOATS · USD · US

This page tracks Ovid Therapeutics Inc.'s OVID:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OVID:BOATS. OVID:BOATS is the stock-level entry point for investors researching Ovid Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ovid Therapeutics Inc. is a public company traded under the ticker OVID in the American market. The company has a market capitalization of approximately $434.87 million. Ovid Therapeutics focuses on developing innovative therapies for neurological disorders.

OVID:BOATSUSDUSUpdated August 28, 2026
Ovid Therapeutics Inc. logo
Ticker
OVID:BOATS
Asset type
Stock
Market cap
$546.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Ovid Therapeutics Inc. OVID:BOATS stock context

This page tracks Ovid Therapeutics Inc.'s OVID:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OVID:BOATS. OVID:BOATS is the stock-level entry point for investors researching Ovid Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ovid Therapeutics Inc. is a public company traded under the ticker OVID in the American market. The company has a market capitalization of approximately $434.87 million. Ovid Therapeutics focuses on developing innovative therapies for neurological disorders.

Latest news from Ovid Therapeutics Inc.

All Ovid Therapeutics Inc. news →

Ovid Therapeutics Inc. earnings calls

Research Ovid Therapeutics Inc.

Alternate listings